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L E T T E R  T O  T H E  E D I T O R
Could a chimeric condition be responsible for unexpected genetic 
syndromes? The role of the single nucleotide polymorphism‐
array analysis
To the Editor
The term “chimerism” refers to the presence of two or more 
genetically distinct cell lineages originating from different 
zygotes in the same individual and can be easily distinguished 
from mosaicism by the extent of genotypic differences along 
the genome. Chimeras generally come to medical attention 
when they contain both male and female cells (46,XX/46,XY 
karyotype), causing disorders of sex development, or a dis-
cordance between external genitalia and chromosomal sex 
(Malan, Vekemans, & Turleau, 2006). In phenotypically nor-
mal individuals, chimerism may come to light only if there is 
a reason to perform genetic testing, that is, blood typing dis-
crepancy (Drexler et al., 2005) or paternity testing (Ramsay et 
al., 2009). All the other chimeric individuals would not be de-
tectable by standard cytogenetic technology, suggesting that 
this phenomenon might be underdiagnosed. About the ori-
gin of chimera individuals, four principal mechanisms have 
been identified as follows: (a) Tetragametic chimera (Green, 
Barton, Jenks, Pearson, & Yates, 1994); (b) Androgenetic 
chimera (Kaiser‐Rogers et al., 2006); (c) Fertilization of an 
ovum and a second polar body by two different spermatozoa 
and subsequent fusion of the two zygotes (Green et al., 1994); 
and (d) Parthenogenetic chimera (Giltay et al., 1998).
Herein, we present two patients characterized by a Silver–
Russell‐ and Prader–Willi‐like phenotypes in which, despite 
a genetically normal karyotype detected in blood, a genome-
wide single nucleotide polymorphism (SNP) array analysis 
on DNA from skin biopsies highlighted a chimeric status.
We discuss SNP array as a technique able to identify chi-
merism also suggesting which one of the complex mecha-
nisms underlying chimera formation could be responsible 
(Biesecker & Spinner, 2013). Subsequently, a custom next‐
generation sequence (NGS) panel was used for chimerism 
quantification (Aloisio et al., 2016).
Based on the whole clinical picture (see Supporting 
Information Appendix S1; Figure 1), Patient 1 (female, 
P1) and Patient 2 (male, P2) underwent a classic and mo-
lecular (Human OmniExpress‐12 Bead Chip; Illumina Inc., 
San Diego, USA) karyotyping on peripheral blood in order 
to study microdeletion/duplication and UPD involved in 
Silver–Russell (SRS) and Prader–Willi (PWS) syndromes. 
This study was approved by an ethics committee and patients 
gave written informed consent to the investigation, according 
to the Declaration of Helsinki. No genetic alterations were 
detected. However, since the clinical presentation of patients 
includes also cutaneous hypopigmented striae following 
Blaschko's line along the trunk (P1) and in the limbs (P2; 
Figure 1c), a SNP array analysis on DNA from skin biopsy 
was performed in order to investigate a mosaic condition. 
Unexpectedly, the results showed a diffusely altered pattern 
of B allele frequencies (BAF) along all the autosomes that 
was consistent with the coexistence of two different geno-
types with an altered ratio between the two haplotypes that 
could be explained by a chimeric status. Quantification of 
alleles frequency on skin fibroblasts, demonstrated the pres-
ence of two genomes with frequency of 30:70% in P1 (Figure 
2a) and of 10:90%, in P2, respectively (Figure 2b). Although 
SNP array analysis shows a normal log ratio graph, the co-
existence of two distinct genomes results in five different 
tracks (AAAA, AAAB, AABB, ABBB, BBBB) based on the 
number of allele combinations in autosomes. Moreover, as 
shown in Figure 2a, we could observe that the AABB splits 
into two tracks because of the 30:70% of coexisting genomes. 
This leads to a patchy BAF scattergram with four‐track inter-
changed with six‐track segments (Figure 2a). This arrange-
ment, although present also in P2, is more difficult to identify 
because of the strong quantitative imbalance of the two coex-
isting genomes (10:90%).
To better evaluate the percentage of chimerism in P1 
and P2, we are taking advantage of a 44‐Amplicon Custom 
Chimerism panel based on Ion AmpliSeq technology as pre-
viously reported by Aloisio et al. (2016, identifying 36 SNPs 
shared with the SNP array chip.
Both NGS data from the blood and the skin DNA sam-
ples were collected thus determining the genotypic layout 
in both tissues. Considering as informative markers only 
SNPs found in homozygous state (i.e., AA) in the blood 
sample and in chimeric state (i.e., AG or GG) in the skin 
sample, it was possible to determine the chimeric allele 
and the two possible genotypes in the skin. So two distinct 
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
2 of 5 |   LETTER TO THE EDITOR
chimerism values were possible (homozygous or hetero-
zygous state): in P1, 16% or 32% and in P2 3.5% or 7%, 
respectively (Table 1); however, the NGS analysis can not 
discriminate the right value. For these reasons, the com-
parison between the SNP array and NGS approach suggests 
that although the quantification of the degree of chimerism 
F I G U R E  1  Clinical features. (a) 
Patient P1 showing asymmetrical face; (b) 
Patient P2 showing a hypotonic appearance, 
obesity, and slight dysmorphic features; 
(c) Patient P2 showing hyperchromic striae 
highlighting the coexistence of two distinct 
cell lines
F I G U R E  2  Scattergrams of B allele frequency (BAF) in single nucleotide polymorphism array analysis. (a) Patient P1’s scattergrams relative 
to chromosome 1 and X. (b) Patient P2’s scattergrams relative to chromosome 1 and X. All BAF graph show a patchy chromosomal pattern due to 
an altered alignments of different allele‐combination segments. In both patients, log ratio appears normal, according with sex
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is more accurate using a NGS approach, the SNP array is 
able not only to provide values that do not significantly de-
viate from those obtained by NGS, but also to discriminate 
which of the two possible percentages reported by the NGS 
output is the most likely.
A further advantage in using the SNP array approach is 
represented by the possibility to determine the parental ori-
gin of the haploid genomes, which contributed to the chimera 
formation, by comparing patients and parents’ SNP array re-
sults. This analysis demonstrated that segments observed in 
the BAF of both P1 and P2 are clearly defined by contribu-
tion of two different maternal alleles (AA or BB, determin-
ing the three allele‐combination segments of AAAA, AABB, 
or BBBB), that joining with the paternal contribution led to 
the five different allele‐combination segments of AAAA, 
AAAB, AABB (divided in our case as explained above), 
ABBB, or BBBB. The changing points between three and 
five allele‐combination segments in autosomes indicate the 
crossover points.
In patient P1, a female, BAF configuration through the 
X‐chromosome shows the same pattern observed in au-
tosomes indicating two different maternal contributions 
(Figure 2a) otherwise, in patient P2, log ratio of the 
X‐chromosome appear normal, according to his gender 
(male) while BAF configuration shows four different tracks 
due to the two maternal contributions in 90:10%, respec-
tively (Figure 2b).
As a final task, the use of SNP array has allowed us to un-
derstand which mechanism has presumably been the cause of 
the chimera formation for both patients. In fact, in our cases, 
the androgenetic and the parthenogenetic chimera were ex-
cluded because their output were incompatible with our SNP 
array’ results as in our BAF two different maternal genomes 
have been showed (Giltay et al., 1998).
Chimerism found in P1 could be explained by a fertiliza-
tion of one nucleus by a normal spermatozoa and endore-
duplication of the polar body (Figure 3). Conversely, the 
pathogenetic mechanism behind the P2 is compatible with a 
tetragametic chimera because the SNP analysis detected five 
haplotypes that could be explained by two oocytes fertilized 
by two spermatozoa or fertilization of an ovum and a second 
polar body by two different spermatozoa (Figure 3). It is re-
ally challenging to discriminate these hypotheses because of 
the high difference between the percentages of the genomes.
In light of chimeric determination in patients, it is possi-
ble to make some considerations on the patients' phenotype. 
Regarding the Silver–Russell‐like phenotype in the female 
patient (P1), it could be explained by the uniparental isodi-
somy in the endoreduplicated polar body genome (a mech-
anism first proposed by Yamazawa et al. (2010. Otherwise, 
the diagnosis of Prader–Willi‐like syndrome for patient P2 
could not be directly explained by its chimeric status. Since 
a MS‐MLPA in the 15q11 region detects a normal pattern 
of methylation and no deletion, we suggest in P2 a PWS‐
like phenotype for which we cannot exclude the chimeric 
involvement.
In conclusion, many cases of whole‐body chimerism are 
reported in literature; unfortunately most of them present 
insufficient molecular information allowing to clearly de-
fine the mechanism involved in the formation of individual 
cases. Nonetheless, several cases of proven tetragametic 
and parthenogenetic chimeras have been described based 
initially on chromosome heteromorphisms, and more re-
cently on genotyping (Russo et al., 2016; Yamazawa et al, 
2010).
Regarding our two patients, the observation of a chime-
ric state was an unexpected finding that could probably ex-
plain the syndromic status at least in P1 while in P2 a genetic 
T A B L E  1  Informative single nucleotide polymorphisms e chimerism percentage calculated by next‐generation sequence approach
Markers Chimeric  
allele count 
(%)
Predicted chimerism %, based on  
Skin genotype
rs SNP Blood genotype Skin genotype Skin genotype
P1 rs1561570 TT C (15%) TC (30%) CC (15%)
rs2077163 TT C (16%) TC (32%) CC (16%)
rs10033900 TT C (17%) TC (34%) CC (17%)
Average chimerism value: 32% 16%
P2 rs2297313 AA G (4%) AG (8%) GG (4%)
rs10489266 AA G (3%) AG (6%) GG (3%)
rs8128316 CC T (3%) CT (6%) TT (3%)
rs744166 GG A (4%) GA (8%) AA (4%)
rs10143250 TT C (4%) TC (8%) CC (4%)
rs132985 TT C (3%) CT (6%) CC (3%)
Average chimerism value: 7.0% 3.5%
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mutation in one of the two coexisting genomes could be the 
causal event.
To assume chimerism, a priori in the absence of substan-
tial clinical abnormalities is very difficult also because, as 
demonstrated in our cases, not all the tissues express both 
genomes, probably leading to an underestimation of this phe-
nomenon. From this perspective, the use of genomewide SNP 
arrays enables simultaneous evaluation of genomic dosage 
allowing insights into the mechanisms by which these abnor-
malities occur. For these reasons, we suggest that the routine 
use of genotyping SNP arrays analysis for the identification of 
“hidden” chimerism in patients with few clinical clues.
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F I G U R E  3  Proposed mechanisms to explain chimera in our patients. Fertilization of the oocyte by a spermatozoa and endoreduplication of 
the polar body in P1. Tetragametic chimera in P2
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